Eric Klann

Eric Klann

Auto-generated profile, based on publicly available information

Eric Klann

New York University

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2010 in Trends in Neurosciences
Verified
Journal Article
Closed access
CHCharles A. Hoeffer
Charles A. Hoeffer
EKEric Klann
Eric Klann

14 April 2013 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JDJennifer C Darnell
Jennifer C Darnell
EKEric Klann
Eric Klann

23 December 2012 in Nature
Verified
Journal Article
Open access
PDF file
ESEmanuela Santini
Emanuela Santini
THThu N. Huynh
Thu N. Huynh
AMAndrew F. MacAskill
Andrew F. MacAskill
ACAdam G. Carter
Adam G. Carter
PPPhilippe Pierre
Philippe Pierre
EKEric Klann
Eric Klann
Mice overexpressing eIF4E show autism-related behaviours and altered synaptic activity in the hippocampus, prefrontal cortex and striatum, and these phenotypes can be rescued with the cap-dependent translation inhibitor 4EGI-1. Aberrant protein synthesis has been hypothesized as one causal mechanism of autism spectrum disorders (ASDs), but the details of which pathways are disrupted remain unknown. Disruption of eIF4E, a key factor for translation initiation, has been associated with human autism, and now two independent papers implicate excessive cap-dependent translation in synaptic and ASD-related behavioural deficits in mice. Nahum Sonenberg and colleagues show that mice lacking 4E-BP2, an eIF4E repressor, display increased translation of neuroligins, synaptic proteins strongly implicated in autism. The mice also display ASD-related behaviors and alterations in hippocampal synaptic activity, which are reversed by normalization of eIF4E activity or neuroligin 1 levels. Eric Klann and colleagues show that mice overexpressing eIF4E also display ASD-related behaviours and altered synaptic activity in the hippocampus, prefrontal cortex and striatum, and that some phenotypes can be rescued with the cap-dependent translation inhibitor 4EGI-1. The converging results from these two studies implicate cap-dependent translation as a potential therapeutic target for treatment of ASD-related symptoms. Autism spectrum disorders (ASDs) are an early onset, heterogeneous group of heritable neuropsychiatric disorders with symptoms that include deficits in social interaction skills, impaired communication abilities, and ritualistic-like repetitive behaviours1,2. One of the hypotheses for a common molecular mechanism underlying ASDs is altered translational control resulting in exaggerated protein synthesis3. Genetic variants in chromosome 4q, which contains the EIF4E locus, have been described in patients with autism4,5. Importantly, a rare single nucleotide polymorphism has been identified in autism that is associated with increased promoter activity in the EIF4E gene6. Here we show that genetically increasing the levels of eukaryotic translation initiation factor 4E (eIF4E) in mice7 results in exaggerated cap-dependent translation and aberrant behaviours reminiscent of autism, including repetitive and perseverative behaviours and social interaction deficits. Moreover, these autistic-like behaviours are accompanied by synaptic pathophysiology in the medial prefrontal cortex, striatum and hippocampus. The autistic-like behaviours displayed by the eIF4E-transgenic mice are corrected by intracerebroventricular infusions of the cap-dependent translation inhibitor 4EGI-1. Our findings demonstrate a causal relationship between exaggerated cap-dependent translation, synaptic dysfunction and aberrant behaviours associated with autism.

1 January 2009 in Genes & Development
Verified
Journal Article
Open access
PDF file
JRJoel D. Richter
Joel D. Richter
EKEric Klann
Eric Klann
Synaptic transmission in neurons is a measure of communication at synapses, the points of contact between axons and dendrites. The magnitude of synaptic transmission is a reflection of the strength of these synaptic connections, which in turn can be altered by the frequency with which the synapses are stimulated, the arrival of stimuli from other neurons in the appropriate temporal window, and by neurotrophic factors and neuromodulators. The ability of synapses to undergo lasting biochemical and morphological changes in response to these types of stimuli and neuromodulators is known as synaptic plasticity, which likely forms the cellular basis for learning and memory, although the relationship between any one form synaptic plasticity and a particular type of memory is unclear. RNA metabolism, particularly translational control at or near the synapse, is one process that controls long-lasting synaptic plasticity and, by extension, several types of memory formation and consolidation. Here, we review recent studies that reflect the importance and challenges of investigating the role of mRNA translation in synaptic plasticity and memory formation.

1 October 2012 in Neuron
Verified
Journal Article
Closed access
ABAditi Bhattacharya
Aditi Bhattacharya
HKHanoch Kaphzan
Hanoch Kaphzan
AAAmanda C. Alvarez-Dieppa
Amanda C. Alvarez-Dieppa
JMJaclyn P. Murphy
Jaclyn P. Murphy
PPPhilippe Pierre
Philippe Pierre
EKEric Klann
Eric Klann

9 September 2015 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
JRJoel D. Richter
Joel D. Richter
GBGary J. Bassell
Gary J. Bassell
EKEric Klann
Eric Klann